Clinical Trials Browser

Interventional × Breast Neoplasm Female × Clear all

NCT05417516 2026-05-22

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Phase 3 Recruiting

Breast Neoplasm Female

NCT03425838 2026-05-20

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Phase 3 Active not recruiting

Breast Neoplasm Female

NCT03096418 2026-01-16

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

Phase 4 Recruiting

50 enrolled 12 charts

Breast Neoplasm Female

NCT04113863 2025-12-18

ATRA

Phase 2 Terminated

Breast Neoplasm Female

NCT07180433 2025-09-18

Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer

Phase NA Not yet recruiting

Breast Neoplasm Female

NCT05071105 2025-05-30

SBRT in Early Breast Cancer in Elderly Women

Phase NA Recruiting

Breast Neoplasm Female

NCT03900884 2024-11-07

PALVEN

Phase 1 Active not recruiting

Breast Neoplasm Female

NCT05027321 2024-09-19

Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies

Phase NA Recruiting

Breast Neoplasm Female

NCT05574816 2024-06-12

Phi-Bra

Phase NA Completed

Breast Neoplasm Female

NCT06234137 2024-01-31

neoPICD

Phase NA Recruiting

Breast Neoplasm Female

NCT03592771 2023-09-05

THRIVE

Phase NA Completed

304 enrolled 18 charts

Breast Neoplasm Female

NCT05969184 2023-08-01

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Phase 2 Unknown

Breast Neoplasm Female

NCT04842799 2023-05-06

BRCA-DIRECT

Phase NA Completed

Breast Neoplasm Female

NCT04674852 2023-01-20

Mayo Designed Soft Tissue Ultrasound-Detectable Marker

Phase NA Completed

Breast Neoplasm Female

NCT05600153 2022-10-31

AvBSR

Phase NA Unknown

Breast Neoplasm Female

NCT05577442 2022-10-19

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasm Female

NCT05244993 2022-07-12

AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer

Phase 2 Unknown

Breast Neoplasm Female

NCT05075512 2021-10-12

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Phase 2 Recruiting

Breast Neoplasm Female

NCT04811378 2021-09-13

HaemoCerTM Application in Breast Cancer Surgery

Phase NA Completed

Breast Neoplasm Female

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Phase NA Completed

Breast Neoplasm Female

NCT03198442 2020-03-24

Breast PET

Phase NA Completed

Breast Neoplasm Female

NCT03638414 2018-08-20

ePainQ

Phase NA Unknown

Breast Neoplasm Female

NCT02957526 2018-07-19

AETAPP

Phase NA Completed

Breast Neoplasm Female

NCT03575845 2018-07-03

The Effect of Yoga on Barriers to Occupational Engagement in African American Breast Cancer Survivors

Phase NA Completed

Breast Neoplasm Female

NCT03069885 2018-05-02

iNPWT in Immediate Breast Reconstruction

Phase NA Unknown

Breast Neoplasm Female

NCT03217539 2018-02-07

WE

Phase NA Completed

133,065 enrolled

Breast Neoplasm Female

NCT03011060 2017-01-10

NACVCAC

Phase 3 Unknown

Breast Neoplasm Female